| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Vandetanib | CCLE | pan-cancer | AAC | -0.099 | 0.04 |
| mRNA | BRD-K48334597 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.04 |
| mRNA | dabrafenib | GDSC1000 | pan-cancer | AAC | 0.064 | 0.04 |
| mRNA | chlorambucil | CTRPv2 | pan-cancer | AAC | -0.066 | 0.04 |
| mRNA | Bexarotene | CTRPv2 | pan-cancer | AAC | -0.076 | 0.04 |
| mRNA | BRD-K30019337 | CTRPv2 | pan-cancer | AAC | 0.15 | 0.04 |
| mRNA | AZD6244 | FIMM | pan-cancer | AAC | -0.36 | 0.04 |
| mRNA | STF-62247 | GDSC1000 | pan-cancer | AAC | -0.068 | 0.05 |
| mRNA | tretinoin:carboplatin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.072 | 0.05 |
| mRNA | BMS-536924 | GDSC1000 | pan-cancer | AAC | 0.067 | 0.05 |